Effect of multiple micronutrient supplementation on survival of HIV-infected children in Uganda: a randomized, controlled trial

Grace Ndeezi, Thorkild Tylleskär, Christopher M Ndugwa, James K Tumwine, Grace Ndeezi, Thorkild Tylleskär, Christopher M Ndugwa, James K Tumwine

Abstract

Background: Micronutrient deficiencies compromise the survival of HIV-infected children in low-income countries. We assessed the effect of multiple micronutrient supplementation on the mortality of HIV-infected children in Uganda.

Methods: In a randomized, controlled trial, 847 children aged one to five years and attending HIV clinics in Uganda were stratified by antiretroviral therapy (ART, n = 85 versus no ART, n = 762). The children were randomized to six months of either: twice the recommended dietary allowance of 14 micronutrients as the intervention arm (vitamins A, B1, B2, niacin, B6, B12, C, D and E, folate, zinc, copper, iodine and selenium); or the standard recommended dietary allowance of six multivitamins (vitamins A, D2, B1, B2, C and niacin) as a comparative "standard-of-care" arm. Mortality was analyzed at 12 months of follow up using Kaplan Meier curves and the log rank test.

Results: Mortality at 12 months was 25 out of 426 (5.9%) children in the intervention arm and 28 out of 421 (6.7%) in the comparative arms: risk ratio 0.9 (95% CI 0.5 - 1.5). Two out of 85 (2.4%) children in the ART stratum died compared with 51 out of 762 (6.7%) in the non-ART stratum. Of those who died in the non-ART stratum, 25 of 383 (6.5%) were in the intervention arm and 26 of 379 (6.9%) in the comparative arm; risk ratio 1.0 (95% CI 0.6 - 1.6). There was no significant difference in survival at 12 months (p = 0.64, log rank test). In addition, there was no significant difference in mean weight-for-height at 12 months; 0.70 +/- 1.43 (95% CI 0.52 - 0.88) for the intervention versus 0.59 +/- 1.15 (95% CI 0.45 - 0.75) in the comparative arm. The mean CD4 cell count; 1024 +/- 592 (95% CI 942 - 1107) versus 1060 +/- 553 (95% CI 985 - 1136) was also similar between the two groups.

Conclusions: Twice the recommended dietary allowance of 14 micronutrients compared with a standard recommended dietary allowance of six multivitamins for six months was well tolerated, but it did not significantly alter mortality, growth or CD4 counts. Future intervention studies should carefully consider: (1) the composition and dosing of the supplements; and (2) the power needed to detect a difference between arms.

Trial registration: ClinicalTrials.gov Identifier: NCT00122941.

Figures

Figure 1
Figure 1
Trial profile.
Figure 2
Figure 2
Kaplan-Meier survival curves of the two arms of the supplementation trial in HIV-infected children at 12 months of follow up.

References

    1. Brahmbhatt H, Kigozi G, Wabwire-Mangen F, Serwadda D, Lutalo T, Nalugoda F, Sewankambo N, Kiduggavu M, Wawer M, Gray R. Mortality in HIV-infected and uninfected children of HIV-infected and uninfected mothers in rural Uganda. J Acquir Immune Defic Syndr. 2006;13:504–508. doi: 10.1097/01.qai.0000188122.15493.0a.
    1. Villamor E, Misegades L, Fataki MR, Mbise RL, Fawzi WW. Child mortality in relation to HIV infection, nutritional status, and socio-economic background. Int J Epidemiol. 2005;13:61–68. doi: 10.1093/ije/dyh378.
    1. Bhutta ZA. Micronutrient needs of malnourished children. Curr Opin Clin Nutr Metab Care. 2008;13:309–314. doi: 10.1097/MCO.0b013e3282fbf5a0.
    1. Eley BS, Sive AA, Abelse L, Kossew G, Cooper M, Hussey GD. Growth and micronutrient disturbances in stable, HIV-infected children in Cape Town. Ann Trop Paediatr. 2002;13:19–23. doi: 10.1179/027249302125000111.
    1. Faruque AS, Ahmed AM, Ahmed T, Islam MM, Hossain MI, Roy SK, Alam N, Kabir I, Sack DA. Nutrition: basis for healthy children and mothers in Bangladesh. J Health Popul Nutr. 2008;13:325–339.
    1. Lartey A. Maternal and child nutrition in Sub-Saharan Africa: challenges and interventions. Proc Nutr Soc. 2008;13:105–108. doi: 10.1017/S0029665108006083.
    1. Semba RD, Tang AM. Micronutrients and the pathogenesis of human immunodeficiency virus infection. Br J Nutr. 1999;13:181–189.
    1. Tamura J, Kubota K, Murakami H, Sawamura M, Matsushima T, Tamura T, Saitoh T, Kurabayshi H, Naruse T. Immunomodulation by vitamin B12: augmentation of CD8+ T lymphocytes and natural killer (NK) cell activity in vitamin B12-deficient patients by methyl-B12 treatment. Clin Exp Immunol. 1999;13:28–32. doi: 10.1046/j.1365-2249.1999.00870.x.
    1. Kupka R, Msamanga GI, Spiegelman D, Rifai N, Hunter DJ, Fawzi WW. Selenium levels in relation to morbidity and mortality among children born to HIV-infected mothers. Eur J Clin Nutr. 2005;13:1250–1258. doi: 10.1038/sj.ejcn.1602236.
    1. Fischer Walker CL, Black RE. Micronutrients and diarrheal disease. Clin Infect Dis. 2007;13(Suppl 1):S73–77. doi: 10.1086/518152.
    1. Villamor E, Fawzi WW. Vitamin A supplementation: implications for morbidity and mortality in children. J Infect Dis. 2000;13(Suppl 1):S122–133. doi: 10.1086/315921.
    1. Coutsoudis A, Bobat RA, Coovadia HM, Kuhn L, Tsai WY, Stein ZA. The effects of vitamin A supplementation on the morbidity of children born to HIV-infected women. Am J Public Health. 1995;13:1076–1081. doi: 10.2105/AJPH.85.8_Pt_1.1076.
    1. Fawzi WW, Mbise RL, Hertzmark E, Fataki MR, Herrera MG, Ndossi G, Spiegelman D. A randomized trial of vitamin A supplements in relation to mortality among human immunodeficiency virus-infected and uninfected children in Tanzania. Pediatr Infect Dis J. 1999;13:127–133. doi: 10.1097/00006454-199902000-00009.
    1. Semba RD, Ndugwa C, Perry RT, Clark TD, Jackson JB, Melikian G, Tielsch J, Mmiro F. Effect of periodic vitamin A supplementation on mortality and morbidity of human immunodeficiency virus-infected children in Uganda: A controlled clinical trial. Nutrition. 2005;13:25–31. doi: 10.1016/j.nut.2004.10.004.
    1. Bhutta ZA, Nizami SQ, Isani Z. Zinc supplementation in malnourished children with persistent diarrhea in Pakistan. Pediatrics. 1999;13:e42. doi: 10.1542/peds.103.4.e42.
    1. Bobat R, Coovadia H, Stephen C, Naidoo KL, McKerrow N, Black RE, Moss WJ. Safety and efficacy of zinc supplementation for children with HIV-1 infection in South Africa: a randomised double-blind placebo-controlled trial. Lancet. 2005;13:1862–1867. doi: 10.1016/S0140-6736(05)67756-2.
    1. Fawzi WW, Msamanga GI, Spiegelman D, Wei R, Kapiga S, Villamor E, Mwakagile D, Mugusi F, Hertzmark E, Essex M, Hunter DJ. A randomized trial of multivitamin supplements and HIV disease progression and mortality. N Engl J Med. 2004;13:23–32. doi: 10.1056/NEJMoa040541.
    1. Jiamton S, Pepin J, Suttent R, Filteau S, Mahakkanukrauh B, Hanshaoworakul W, Chaisilwattana P, Suthipinittharm P, Shetty P, Jaffar S. A randomized trial of the impact of multiple micronutrient supplementation on mortality among HIV-infected individuals living in Bangkok. AIDS. 2003;13:2461–2469. doi: 10.1097/00002030-200311210-00008.
    1. Luabeya KK, Mpontshane N, Mackay M, Ward H, Elson I, Chhagan M, Tomkins A, Van den Broeck J, Bennish ML. Zinc or multiple micronutrient supplementation to reduce diarrhea and respiratory disease in South African children: a randomized controlled trial. PLoS One. 2007;13:e541. doi: 10.1371/journal.pone.0000541.
    1. Semba RD, Kumwenda J, Zijlstra E, Ricks MO, van Lettow M, Whalen C, Clark TD, Jorgensen L, Kohler J, Kumwenda N, Taha TE, Harries AD. Micronutrient supplements and mortality of HIV-infected adults with pulmonary TB: a controlled clinical trial. Int J Tuberc Lung Dis. 2007;13:854–859.
    1. UNICEF, The Micronutrient Initiative. Vitamin & mineral deficiency. A global progress report. Vol. 13. New York: UNICEF and Micronutrient Initiative; 2004.
    1. Baum MK, Shor-Posner G. Nutritional requirements in HIV-1 infection. AIDS. 1994;13:715. doi: 10.1097/00002030-199405000-00029.
    1. Kelly P, Katubulushi M, Todd J, Banda R, Yambayamba V, Fwoloshi M, Zulu I, Kafwembe E, Yavwa F, Sanderson IR, Tomkins A. Micronutrient supplementation has limited effects on intestinal infectious disease and mortality in a Zambian population of mixed HIV status: a cluster randomized trial. Am J Clin Nutr. 2008;13:1010–1017.
    1. WHO. Case definitions of HIV for surveillance and revised clinical staging and immunological classification of HIV-related disease in adults and children. Geneva, Switzerland: WHO; 2006.
    1. Rahil-Khazen R, Henriksen H, Bolann BJ, Ulvik RJ. Validation of inductively coupled plasma atomic emission spectrometry technique (ICP-AES) for multi-element analysis of trace elements in human serum. Scand J Clin Lab Invest. 2000;13:677–686. doi: 10.1080/00365510050216402.
    1. Berhane R, Bagenda D, Marum L, Aceng E, Ndugwa C, Bosch RJ, Olness K. Growth failure as a prognostic indicator of mortality in pediatric HIV infection. Pediatrics. 1997;13:E7. doi: 10.1542/peds.100.1.e7.
    1. WHO. WHO Anthro 2005. Geneva: WHO; 2005.
    1. Renwick AG. Toxicology of micronutrients: adverse effects and uncertainty. J Nutr. 2006;13:493S–501S.
    1. McDermid JM, Jaye A, van der Loeff Schim MF, Todd J, Bates C, Austin S, Jeffries D, Awasana AA, Whittlex AA, Prentice A. Elevated iron status strongly predicts mortality in West African adults with HIV infection. J Acquir Immune Defic Syndr. 2007;13:498–507. doi: 10.1097/QAI.0b013e31815b2d4b.
    1. Amolo Okero F, Aceng E, Madraa E, Namagala E, Serutoke J. Scaling up antiretroviral therapy: experience in Uganda. Geneva: WHO; 2003.
    1. Sutcliffe CG, van Dijk JH, Bolton C, Persaud D, Moss WJ. Effectiveness of antiretroviral therapy among HIV-infected children in sub-Saharan Africa. Lancet Infect Dis. 2008;13:477–489. doi: 10.1016/S1473-3099(08)70180-4.
    1. Walker AS, Mulenga V, Sinyinza F, Lishimpi K, Nunn A, Chintu C, Gibb DM. Determinants of survival without antiretroviral therapy after infancy in HIV-1-infected Zambian children in the CHAP Trial. J Acquir Immune Defic Syndr. 2006;13:637–645. doi: 10.1097/01.qai.0000226334.34717.dc.
    1. Ndagije F, Baribwira C, Coulter JB. Micronutrients and T-cell subsets: a comparison between HIV-infected and uninfected, severely malnourished Rwandan children. Ann Trop Paediatr. 2007;13:269–275. doi: 10.1179/146532807X245652.
    1. Drain PK, Kupka R, Msamanga GI, Urassa W, Mugusi F, Fawzi WW. C-reactive protein independently predicts HIV-related outcomes among women and children in a resource-poor setting. AIDS. 2007;13:2067–2075. doi: 10.1097/QAD.0b013e32826fb6c7.
    1. Irlam JH, Visser ME, Rollins N, Siegfried N. Micronutrient supplementation in children and adults with HIV infection. Cochrane Database Syst Rev. 2005. p. CD003650.

Source: PubMed

Sponsors et collaborateurs

Les conditions médicales

Interventions en matière de drogue

3
S'abonner